Letter: extending FIT from DG30 to NG12 patients. Letter: faecal immunochemical testing for adults with symptoms of colorectal cancer - ready for prime time? Authors' reply: a unified approach to safety netting negative FITs is required
Aliment Pharmacol Ther
.
2020 Oct;52(8):1420-1421.
doi: 10.1111/apt.16082.
Authors
Brian D Nicholson
1
,
James E East
2
,
Jason Oke
1
,
Nia Wyn Roberts
3
,
Tim James
4
,
Brian Shine
4
Affiliations
1
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
2
Translational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
3
Bodleian Health Care Libraries, University of Oxford, Oxford, UK.
4
Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
PMID:
33105974
DOI:
10.1111/apt.16082
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Adult
Colorectal Neoplasms* / diagnosis
Humans
Occult Blood*
Primary Health Care
Retrospective Studies